{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:30:50Z","timestamp":1790620250255,"version":"4.1.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of this review is to consider whether multiple pathogens have roles in prostate cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We have reviewed case control studies in which infectious pathogens in prostate cancer were compared to normal and benign prostate tissues. We also reviewed additional evidence from relevant published articles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We confirmed that high risk human papilloma viruses are a probable cause of prostate cancer. We judged<jats:italic>Escherichia coli<\/jats:italic>,<jats:italic>Cutibacterium acnes<\/jats:italic>,<jats:italic>Neisseria gonorrhoea<\/jats:italic>,<jats:italic>Herpes simplex<\/jats:italic>, Epstein Barr virus and Mycoplasmas as each having possible but unproven roles in chronic prostatic inflammation and prostate cancer. We judged Cytomegalovirus, Chlamydia trachomatis, Trichomonas vaginalis and the Polyoma viruses as possible but unlikely to have a role in prostate cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and actions<\/jats:title><jats:p>The most influential cause of prostate cancer appears to be infection induced chronic inflammation. Given the high prevalence of prostate cancer it is important for action to can be taken without waiting for additional conclusive evidence. These include:<jats:list list-type=\"order\"><jats:list-item><jats:p>Encouragement of all boys (as well as girls) to have HPV vaccines<\/jats:p><\/jats:list-item><jats:list-item><jats:p>The vigorous use of antibiotics to treat all bacterial pathogens identified in the urogenital tract<\/jats:p><\/jats:list-item><jats:list-item><jats:p>The use of antiviral medications to control herpes infections<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Education about safe sexual practices<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p><\/jats:sec>","DOI":"10.1186\/s13027-022-00427-1","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T11:03:54Z","timestamp":1653908634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Multiple pathogens and prostate cancer"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2385-8304","authenticated-orcid":false,"given":"James S.","family":"Lawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K.","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"427_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13027-020-00305-8","volume":"15","author":"JS Lawson","year":"2020","unstructured":"Lawson JS, Glenn WK. Evidence for a causal role by human papillomaviruses in prostate cancer: a systematic review. Infect Agent Cancer. 2020;15:41.","journal-title":"Infect Agent Cancer"},{"key":"427_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021. https:\/\/doi.org\/10.1002\/ijc.33588.","journal-title":"Int J Cancer"},{"key":"427_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/02841869109092336","volume":"30","author":"CS Muir","year":"1991","unstructured":"Muir CS, Nectoux J, Staszewski J. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol. 1991;30:133\u201340.","journal-title":"Acta Oncol"},{"key":"427_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.canlet.2017.11.011","volume":"414","author":"S Kumar","year":"2018","unstructured":"Kumar S, Singh R, Malik S, Manne U, Mishra M. Prostate cancer health disparities: an immuno-biological perspective. Cancer Lett. 2018;414:153\u201365.","journal-title":"Cancer Lett"},{"key":"427_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00001648-199503000-00017","volume":"6","author":"JL Stanford","year":"1995","unstructured":"Stanford JL, Herrington LJ, Schwartz SM, Weiss NS. Breast cancer incidence in Asian migrants to the US and their descendants. Epidemiology. 1995;6:181\u20133.","journal-title":"Epidemiology"},{"key":"427_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/jmv.21754","volume":"82","author":"H Johal","year":"2010","unstructured":"Johal H, Faedo M, Faltas J, Lau A, Mousina R, Cozzi P, Defazio A, Rawlinson WD. DNA of mouse mammary tumor virus-like virus is present in human tumors influenced by hormones. J Med Virol. 2010;82:1044\u201350.","journal-title":"J Med Virol"},{"key":"427_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41523-019-0136-4","volume":"5","author":"JS Lawson","year":"2019","unstructured":"Lawson JS, Glenn WK. Evidence for a causal role by mouse mammary tumour-like virus in human breast cancer. NPJ Breast Cancer. 2019;5:40.","journal-title":"NPJ Breast Cancer"},{"key":"427_CR8","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295\u2013330.","journal-title":"Proc R Soc Med"},{"key":"427_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1353\/obs.2020.0003","volume":"6","author":"S Kleinberg","year":"2020","unstructured":"Kleinberg S. On the use and abuse of Hill\u2019s viewpoints on causality. Obs Stud. 2020;6:17\u20139.","journal-title":"Obs Stud"},{"issue":"4682","key":"427_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/bmj.2.4682.739","volume":"2","author":"R Doll","year":"1950","unstructured":"Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950;2(4682):739\u201348.","journal-title":"Br Med J"},{"key":"427_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0022-5347(17)38476-8","volume":"145","author":"PJ McNicol","year":"1991","unstructured":"McNicol PJ, Dodd JG. High prevalence of human papillomavirus in prostate tissues. Urol J. 1991;145:850\u20133.","journal-title":"Urol J"},{"key":"427_CR12","first-page":"5991","volume":"52","author":"K Anwar","year":"1992","unstructured":"Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res. 1992;52:5991\u20136.","journal-title":"Cancer Res"},{"key":"427_CR13","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/S0022-5347(17)37040-4","volume":"148","author":"GK Ibrahim","year":"1992","unstructured":"Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson SM, et al. Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol. 1992;148:1822\u20136.","journal-title":"J Urol"},{"key":"427_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ijc.2910520306","volume":"52","author":"A Rotola","year":"1992","unstructured":"Rotola A, Monini P, Di Luca D, Savioli A, Simone R, Secchiero P, et al. Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer. 1992;52:359\u201365.","journal-title":"Int J Cancer"},{"key":"427_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0022-5347(17)36103-7","volume":"149","author":"JG Dodd","year":"1993","unstructured":"Dodd JG, Paraskevas M, McNicol PJ. Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol. 1993;149:400\u20132.","journal-title":"J Urol"},{"key":"427_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ijc.2910640209","volume":"64","author":"C Moyret-Lalle","year":"1995","unstructured":"Moyret-Lalle C, Mar\u00e7ais C, Jacquemier J, Moles JP, Daver A, Soret JY, et al. Ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer. 1995;64:124\u20139.","journal-title":"Int J Cancer"},{"key":"427_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/(SICI)1097-0045(199602)28:2<117::AID-PROS7>3.0.CO;2-D","volume":"28","author":"L Wideroff","year":"1996","unstructured":"Wideroff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr W, et al. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate. 1996;28:117\u201323.","journal-title":"Prostate"},{"key":"427_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0090-4295(97)00126-X","volume":"50","author":"MK Terris","year":"1997","unstructured":"Terris MK, Peehl DM. Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology. 1997;50:150\u20136.","journal-title":"Urology"},{"key":"427_CR19","first-page":"823","volume":"59","author":"J Serth","year":"1999","unstructured":"Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res. 1999;59:823\u20135.","journal-title":"Cancer Res"},{"key":"427_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/172460080401900401","volume":"19","author":"F Carozzi","year":"2004","unstructured":"Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, et al. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers. 2004;19:257\u201361.","journal-title":"Int J Biol Markers"},{"key":"427_CR21","doi-asserted-by":"crossref","first-page":"e2015005","DOI":"10.4178\/epih\/e2015005","volume":"37","author":"GJ Leiros","year":"2015","unstructured":"Leiros GJ, Galliano SR, Sember ME, Kahn T, Schwarz E, Eiguchi K. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Epidemiol Health. 2015;37:e2015005.","journal-title":"BMC Epidemiol Health"},{"key":"427_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1590\/S0074-02762009000400024","volume":"104","author":"RV Silvestre","year":"2009","unstructured":"Silvestre RV, Leal MF, Demachki S, Nahum MC, Bernardes JG, Rabenhorst SH, et al. Low frequency of human papillomavirus detection in prostate tissue from individuals from northern Brazil. Mem Inst Oswaldo Cruz. 2009;104:665\u20137.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"427_CR23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/1471-2407-10-326","volume":"10","author":"ML Martinez-Fierro","year":"2010","unstructured":"Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, et al. Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer. 2010;10:326.","journal-title":"BMC Cancer"},{"key":"427_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/00365548.2010.502904","volume":"43","author":"A Aghakhani","year":"2011","unstructured":"Aghakhani A, Hamkar R, Parvin M, Ghavami N, Nadri M, Pakfetrat A, et al. The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis. 2011;43:64\u20139.","journal-title":"Scand J Infect Dis"},{"key":"427_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s12253-010-9357-4","volume":"17","author":"AC Chen","year":"2011","unstructured":"Chen AC, Waterboer T, Keleher A, Morrison B, Jindal S, McMillan D, et al. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathol Oncol Res. 2011;17:613\u20137.","journal-title":"Pathol Oncol Res"},{"key":"427_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/jmv.23367","volume":"84","author":"R Tachezy","year":"2012","unstructured":"Tachezy R, Hrbacek J, Heracek J, Salakova M, Smahelova J, Ludvikova V, et al. HPV persistence and its oncogenic role in prostate tumors. J Med Virol. 2012;84:1636\u201345.","journal-title":"J Med Virol"},{"key":"427_CR27","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.7314\/APJCP.2013.14.5.3305","volume":"14","author":"E Ghasemian","year":"2013","unstructured":"Ghasemian E, Monavari SH, Irajian GR, Jalali Nodoshan MR, Roudsari RV, Yahyapour Y. Evaluation of human papillomavirus infections in prostatic disease: a cross-sectional study in Iran. Asian Pac J Cancer Prev. 2013;14:3305\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"427_CR28","first-page":"707","volume":"18","author":"M Mokhtari","year":"2013","unstructured":"Mokhtari M, Taghizadeh F, Hani M. Is prostatic adenocarcinoma in a relationship with human papilloma virus in Isfahan -Iran. J Res Med Sci. 2013;18:707\u201310.","journal-title":"J Res Med Sci"},{"key":"427_CR29","doi-asserted-by":"publisher","first-page":"12765","DOI":"10.1007\/s13277-014-2604-7","volume":"35","author":"V Michopoulou","year":"2014","unstructured":"Michopoulou V, Derdas SP, Symvoulakis E, Mourmouras N, Nomikos A, Delakas D, et al. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients. Tumour Biol. 2014;35:12765\u201373.","journal-title":"Tumour Biol"},{"key":"427_CR30","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1038\/srep07822","volume":"5","author":"N Singh","year":"2015","unstructured":"Singh N, Hussain S, Kakkar N, Singh SK, Sobti RC, Bharadwaj M. Implication of high risk Human papillomavirus HR-HPV infection in prostate cancer in Indian population: a pioneering case-control analysis. Sci Rep. 2015;5:7822.","journal-title":"Sci Rep"},{"key":"427_CR31","first-page":"501","volume":"22","author":"L Huang","year":"2016","unstructured":"Huang L, Wu MG, He J, Wei ZS, L\u00fc WX, Song XJ, et al. Correlation of highrisk HPV 16\/18 infections with prostate cancer. Zhonghua Nan Ke Xue. 2016;22:501\u20135.","journal-title":"Zhonghua Nan Ke Xue"},{"key":"427_CR32","first-page":"4863","volume":"17","author":"MI D\u00e1vila-Rodr\u00edguez","year":"2016","unstructured":"D\u00e1vila-Rodr\u00edguez MI, Ignacio Morales CV, Arag\u00f3n Tovar AR, Olache Jimenez D, Castel\u00e1n Maldonado E, Lara Miranda S, et al. Human papilloma virus detection by INNOLiPA HPV in prostate tissue from men of Northeast Mexico. Asian Pac J Cancer Prev. 2016;17:4863\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"427_CR33","first-page":"3953","volume":"17","author":"F Atashafrooz","year":"2016","unstructured":"Atashafrooz F, Rokhbakhsh-Zamin F. Frequency and type distribution of human papilloma virus in patients with prostate Cancer, Kerman, southeast of Iran. Asian Pac J Cancer Prev. 2016;17:3953\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"427_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1590\/1678-4685-gmb-2017-0331","volume":"41","author":"O Medel-Flores","year":"2018","unstructured":"Medel-Flores O, Valenzuela-Rodr\u00edguez VA, Ocadiz-Delgado R, Castro-Mu\u00f1oz LJ, Hern\u00e1ndez-Leyva S, Lara-Hern\u00e1ndez G, et al. Association between HPV infection and prostate cancer in a Mexican population. Genet Mol Biol. 2018;41:781\u20139.","journal-title":"Genet Mol Biol"},{"key":"427_CR35","doi-asserted-by":"publisher","first-page":"106913","DOI":"10.1016\/j.intimp.2020.106913","volume":"88","author":"JS Nahand","year":"2020","unstructured":"Nahand JS, Esghaei M, Hamidreza Monavari S, Moghoofei M, Jalal Kiani S, Mostafaei S, Mirzaei H, Bokharaei-Salim F. The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in Prostate cancer. Int Immunopharmacol. 2020;88:106913.","journal-title":"Int Immunopharmacol"},{"key":"427_CR36","doi-asserted-by":"publisher","first-page":"104576","DOI":"10.1016\/j.micpath.2020.104576","volume":"152","author":"M Fatemipour","year":"2021","unstructured":"Fatemipour M, Nahand JS, Fard Azar ME, Baghi HB, Taghizadieh M, Sorayyayi S, Hussen BM, Mirzaei H, Moghoofei M, Bokharaei-Salim F. Human papillomavirus and prostate cancer: the role of viral expressed proteins in the inhibition of anoikis and induction of metastasis. Microb Pathog. 2021;152:104576.","journal-title":"Microb Pathog"},{"key":"427_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pros.22562","volume":"73","author":"NJ Whitaker","year":"2013","unstructured":"Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS. Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Prostate. 2013;73:236\u201341.","journal-title":"Prostate"},{"key":"427_CR38","doi-asserted-by":"publisher","first-page":"11874","DOI":"10.1073\/pnas.91.25.11874","volume":"91","author":"JS Rhim","year":"1994","unstructured":"Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen LS, et al. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc Natl Acad Sci U S A. 1994;91:11874\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"427_CR39","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1128\/JVI.02859-13","volume":"88","author":"DM Sch\u00fctze","year":"2014","unstructured":"Sch\u00fctze DM, Snijders PJ, Bosch L, Kramer D, Meijer CJ, Steenbergen RD. Differential in vitro immortalization capacity of eleven (probable) high-risk human papillomavirus types. J Virol. 2014;88:1714\u201324.","journal-title":"J Virol"},{"key":"427_CR40","doi-asserted-by":"publisher","first-page":"8500","DOI":"10.3390\/ijerph18168500","volume":"18","author":"F Crocetto","year":"2021","unstructured":"Crocetto F, Arcaniolo D, Napolitano L, Barone B, La Rocca R, Capece M, Caputo VF, Imbimbo C, De Sio M, Calace FP, Manfredi C. Impact of sexual activity on the risk of male genital tumors: a systematic review of the literature. Int J Environ Res Public Health. 2021;18:8500.","journal-title":"Int J Environ Res Public Health"},{"key":"427_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/v9080211","volume":"9","author":"D Guenat","year":"2017","unstructured":"Guenat D, Hermetet F, Pr\u00e9tet J-L, Mougin C. Exosomes and other extracellular vesicles in HPV transmission and carcinogenesis. Viruses. 2017;9:211.","journal-title":"Viruses"},{"key":"427_CR42","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s40618-019-01069-8","volume":"42","author":"S La Vignera","year":"2019","unstructured":"La Vignera S, Condorelli RA, Cannarella R, Giacone F, Mongioi L, Scalia G, et al. High rate of detection of ultrasound signs of prostatitis in patients with HPV-DNA persistence on semen: role of ultrasound in HPV-related male accessory gland infection. J Endocrinol Invest. 2019;42:1459\u201365.","journal-title":"J Endocrinol Invest"},{"key":"427_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7150\/jca.37235","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang Y, Qin Z, Gao X, Xing Q, Li R, et al. Correlation between prostatitis, benign prostatic hyperplasia and prostate cancer: a systematic review and meta-analysis. J Cancer. 2020;11:177\u201389.","journal-title":"J Cancer"},{"key":"427_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13027-017-0157-2","volume":"12","author":"WK Glenn","year":"2017","unstructured":"Glenn WK, Ngan CC, Amos TG, Edwards RJ, Swift J, Lutze-Mann L, et al. High risk human papillomaviruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer. Infect Agent Cancer. 2017;12:46.","journal-title":"Infect Agent Cancer"},{"key":"427_CR45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1158\/1055-9965.EPI-17-0040","volume":"26","author":"SL Sudenga","year":"2017","unstructured":"Sudenga SL, Torres BN, Silva R, Villa LL, Lazcano-Ponce E, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR. Comparison of the natural history of genital HPV infection among men by country: Brazil, Mexico, and the United States. Cancer Epidemiol Biomark Prev. 2017;26:1043\u201352.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"427_CR46","doi-asserted-by":"publisher","first-page":"e531","DOI":"10.1016\/S2352-3018(21)00108-9","volume":"8","author":"F Wei","year":"2021","unstructured":"Wei F, Gaisa MM, D\u2019Souza G, Xia N, Giuliano AR, Hawes SE, Gao L, Cheng SH, Don\u00e0 MG, Goldstone SE, et al. Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies. Lancet HIV. 2021;8:e531\u201343.","journal-title":"Lancet HIV"},{"key":"427_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea MG, Dom\u00ednguez-Andr\u00e9s J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, Joosten LAB, van der Meer JWM, Mhlanga MM, Mulder WJM, Riksen NP, Schlitzer A, Schultze JL, Stabell Benn C, Sun JC, Xavier RJ, Latz E. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20:375\u201388.","journal-title":"Nat Rev Immunol"},{"key":"427_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/1471-2334-14-312","volume":"14","author":"IA Korostil","year":"2014","unstructured":"Korostil IA, Regan DG. The potential impact of HPV-16 reactivation on prevalence in older Australians. BMC Infect Dis. 2014;14:312.","journal-title":"BMC Infect Dis"},{"key":"427_CR49","doi-asserted-by":"publisher","first-page":"e97787","DOI":"10.1371\/journal.pone.0097787","volume":"9","author":"K Ohba","year":"2014","unstructured":"Ohba K, Ichiyama K, Yajima M, Gemma N, Nikaido M, Wu Q, et al. in vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction. PLoS ONE. 2014;9:e97787.","journal-title":"PLoS ONE"},{"key":"427_CR50","doi-asserted-by":"publisher","first-page":"e02234","DOI":"10.1128\/mBio.02234-14","volume":"5","author":"VC Vieira","year":"2014","unstructured":"Vieira VC, Leonard B, White EA, Starrett GJ, Temiz NA, Lorenz LD, et al. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B. MBio. 2014;5:e02234-e2314.","journal-title":"MBio"},{"issue":"Supplement_4","key":"427_CR51","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1093\/infdis\/jiaa621","volume":"224","author":"LE Markowitz","year":"2021","unstructured":"Markowitz LE, Schiller JT. Human papillomavirus vaccines. J Infect Dis. 2021;224(Supplement_4):S367\u201378.","journal-title":"J Infect Dis"},{"key":"427_CR52","doi-asserted-by":"publisher","first-page":"102411","DOI":"10.1016\/j.anaerobe.2021.102411","volume":"71","author":"I Dekio","year":"2021","unstructured":"Dekio I, Asahina A, Shah HN. Unravelling the eco-specificity and pathophysiological properties of Cutibacterium species in the light of recent taxonomic changes. Anaerobe. 2021;71:102411.","journal-title":"Anaerobe"},{"key":"427_CR53","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10552-006-0054-2","volume":"17","author":"O Alexeyev","year":"2006","unstructured":"Alexeyev O, Bergh J, Marklund I, Thellenberg-Karlsson C, Wiklund F, Gr\u00f6nberg H, Bergh A, Elgh F. Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden). Cancer Causes Control. 2006;17:1127\u201333.","journal-title":"Cancer Causes Control"},{"key":"427_CR54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/pros.20680","volume":"68","author":"KS Sfanos","year":"2008","unstructured":"Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate. 2008;68:306\u201320.","journal-title":"Prostate"},{"key":"427_CR55","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/sj.bjc.6605757","volume":"103","author":"G Severi","year":"2010","unstructured":"Severi G, Shannon BA, Hoang HN, Baglietto L, English DR, Hopper JL, Pedersen J, Southey MC, Sinclair R, Cohen RJ, Giles GG. Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population-based case\u2013control study. Br J Cancer. 2010;103:411\u20135.","journal-title":"Br J Cancer"},{"key":"427_CR56","doi-asserted-by":"publisher","first-page":"e90324","DOI":"10.1371\/journal.pone.0090324","volume":"9","author":"Y Bae","year":"2014","unstructured":"Bae Y, Ito T, Iida T, Uchida K, Sekine M, Nakajima Y, Kumagai J, Yokoyama T, Kawachi H, Akashi T, Eishi Y. Intracellular Propionibacterium acnes infection in glandular epithelium and stromal macrophages of the prostate with or without cancer. PLoS ONE. 2014;9:e90324.","journal-title":"PLoS ONE"},{"key":"427_CR57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13027-016-0074-9","volume":"11","author":"S Davidsson","year":"2016","unstructured":"Davidsson S, Molling P, Rider JR, Unemo M, Karlsson MG, Carlsson J, Andersson SO, Elgh F, Soderquis B, Andren O. Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infect Agent Cancer. 2016;11:26.","journal-title":"Infect Agent Cancer"},{"key":"427_CR58","doi-asserted-by":"publisher","first-page":"e0169984","DOI":"10.1371\/journal.pone.0169984","volume":"12","author":"T Kakegawa","year":"2017","unstructured":"Kakegawa T, Bae Y, Ito T, Uchida K, Sekine M, Nakajima Y, Furukawa A, Suzuki Y, Kumagai J, Akashi T, Eishi Y. Frequency of propionibacterium acnes infection in prostate glands with negative biopsy results is an independent risk factor for prostate cancer in patients with increased serum PSA Titers. PLoS ONE. 2017;12:e0169984.","journal-title":"PLoS ONE"},{"key":"427_CR59","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1097\/01.ju.0000158161.15277.78","volume":"173","author":"RJ Cohen","year":"2005","unstructured":"Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol. 2005;173:1969\u201374.","journal-title":"J Urol"},{"key":"427_CR60","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2180-10-126","volume":"10","author":"JB Drott","year":"2010","unstructured":"Drott JB, Alexeyev O, Bergstr\u00f6m P, Elgh F, Olsson J. Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells. BMC Microbiol. 2010;10:126.","journal-title":"BMC Microbiol"},{"key":"427_CR61","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/ced.14239","volume":"45","author":"C Dessinioti","year":"2020","unstructured":"Dessinioti C, Dreno B. Acne treatments: future trajectories. Clin Exp Dermatol. 2020;45:955\u201361.","journal-title":"Clin Exp Dermatol"},{"key":"427_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/apm.13021","volume":"128","author":"H Br\u00fcggemann","year":"2020","unstructured":"Br\u00fcggemann H, Al-Zeer MA. Bacterial signatures and their inflammatory potentials associated with prostate cancer. APMIS. 2020;128:80\u201391.","journal-title":"APMIS"},{"key":"427_CR63","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/pros.24063","volume":"80","author":"S Jain","year":"2020","unstructured":"Jain S, Samal AG, Das B, Pradhan B, Sahu N, Mohapatra D, Behera PK, Satpathi PS, Mohanty AK, Satpathi S, Senapati S. Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells. Prostate. 2020;80:1341\u201352.","journal-title":"Prostate"},{"key":"427_CR64","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","volume":"15","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15:425\u201330.","journal-title":"Clin Cancer Res"},{"key":"427_CR65","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1128\/JCM.40.12.4445-4449.2002","volume":"40","author":"J Ruiz","year":"2002","unstructured":"Ruiz J, Simon K, Horcajada JP, Velasco M, Barranco M, Roig G, Moreno-Mart\u00ednez A, Mart\u00ednez JA, Jim\u00e9nez de Anta T, Mensa J, Vila J. Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol. 2002;40:4445\u20139.","journal-title":"J Clin Microbiol"},{"key":"427_CR66","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.3390\/ijms20215295","volume":"20","author":"EA Alhinai","year":"2019","unstructured":"Alhinai EA, Walton GE, Commane DM. The role of the gut microbiota in colorectal cancer causation. Int J Mol Sci. 2019;20:5295.","journal-title":"Int J Mol Sci"},{"key":"427_CR67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.15698\/mic2016.09.524","volume":"3","author":"SA Hill","year":"2016","unstructured":"Hill SA, Masters TL, Wachter J. Gonorrhea: an evolving disease of the new millennium. Microb Cell. 2016;3:371\u201389.","journal-title":"Microb Cell"},{"key":"427_CR68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos KS, Yegnasu Bramanian S, Nelson WG, De Marzo AM. The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol. 2018;15:11\u201324.","journal-title":"Nat Rev Urol"},{"key":"427_CR69","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0090-4295(75)90627-5","volume":"6","author":"MY Heshmat","year":"1975","unstructured":"Heshmat MY, Kovi J, Herson J, Jones GW, Jackson MA. Epidemiologic association between Gonorrhea and prostatic carcinoma. Urology. 1975;6:457\u201360.","journal-title":"Urology"},{"key":"427_CR70","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0022-5347(17)55039-9","volume":"125","author":"LH Baker","year":"1981","unstructured":"Baker LH, Mebust WK, Chin TD, Chapman AL, Hinthorn D, Towle D. The relationship of herpesvirus to carcinoma of the prostate. J Urol. 1981;125:370\u20134.","journal-title":"J Urol"},{"key":"427_CR71","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/jech.39.3.227","volume":"39","author":"RE Lees","year":"1985","unstructured":"Lees RE, Steele R, Wardle D. Arsenic, syphilis, and cancer of the prostate. J Epidemiol Community Health. 1985;39:227\u201330.","journal-title":"J Epidemiol Community Health"},{"key":"427_CR72","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/pros.2990060411","volume":"6","author":"T Mishina","year":"1985","unstructured":"Mishina T, Watanabe H, Araki H, Nakao M. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate. 1985;6:423\u201336.","journal-title":"Prostate"},{"key":"427_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/pros.2990100111","volume":"10","author":"H Checkoway","year":"1987","unstructured":"Checkoway H, DiFerdinando G, Hulka BS, Mickey DD. Medical, life-style, and occupational risk factors for prostate cancer. Prostate. 1987;10:79\u201388.","journal-title":"Prostate"},{"key":"427_CR74","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/bjc.1988.74","volume":"57","author":"GD Honda","year":"1988","unstructured":"Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer. 1988;57:326\u201331.","journal-title":"Br J Cancer"},{"key":"427_CR75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/pros.2990140205","volume":"14","author":"K Oishi","year":"1989","unstructured":"Oishi K, Okada K, Yoshida O, Yamabe H, Ohno Y, Hayes RB, Schroeder FH. Case-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factors. Prostate. 1989;14:117\u201322.","journal-title":"Prostate"},{"key":"427_CR76","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jech.47.6.450","volume":"47","author":"C La Vecchia","year":"1993","unstructured":"La Vecchia C, Franceschi S, Talamini R, Negri E, Boyle P, D\u2019Avanzo B. Marital status, indicators of sexual activity and prostatic cancer. J Epidemiol Community Health. 1993;47:450\u20133.","journal-title":"J Epidemiol Community Health"},{"key":"427_CR77","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF01830728","volume":"5","author":"RA Hiatt","year":"1994","unstructured":"Hiatt RA, Armstrong MA, Klatsky AL, Sidney S. Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control. 1994;5:66\u201372.","journal-title":"Cancer Causes Control"},{"key":"427_CR78","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/bjc.1996.610","volume":"74","author":"M Ili\u0107","year":"1996","unstructured":"Ili\u0107 M, Vlajinac H, Marinkovi\u0107 J. Case-control study of risk factors for prostate cancer. Br J Cancer. 1996;74:1682\u20136.","journal-title":"Br J Cancer"},{"key":"427_CR79","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<699::AID-IJC12>3.0.CO;2-7","volume":"80","author":"CC Hsieh","year":"1999","unstructured":"Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS, Trichopoulos D. Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer. 1999;80:699\u2013703.","journal-title":"Int J Cancer"},{"key":"427_CR80","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1054\/bjoc.1999.0986","volume":"82","author":"RB Hayes","year":"2000","unstructured":"Hayes RB, Pottern LM, Strickler H, Rabkin C, Pope V, Swanson GM, Greenberg RS, Schoenberg JB, Liff J, Schwartz AG, Hoover RN, Fraumeni JF Jr. Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer. 2000;82:718\u201325.","journal-title":"Br J Cancer"},{"key":"427_CR81","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/aje\/153.12.1152","volume":"153","author":"KA Rosenblatt","year":"2001","unstructured":"Rosenblatt KA, Wicklund KG, Stanford JL. Sexual factors and the risk of prostate cancer. Am J Epidemiol. 2001;153:1152\u20138.","journal-title":"Am J Epidemiol"},{"key":"427_CR82","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1023\/B:CACO.0000036172.63845.d4","volume":"15","author":"M Sanderson","year":"2004","unstructured":"Sanderson M, Coker AL, Logan P, Zheng W, Fadden MK. Lifestyle and prostate cancer among older African-American and Caucasian men in South Carolina. Cancer Causes Control. 2004;15:647\u201355.","journal-title":"Cancer Causes Control"},{"key":"427_CR83","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10552-004-3486-6","volume":"16","author":"DA Patel","year":"2005","unstructured":"Patel DA, Bock CH, Schwartz K, Wenzlaff AS, Demers RY, Severson RK. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case-control study in Wayne County, Michigan. Cancer Causes Control. 2005;16:263\u201373.","journal-title":"Cancer Causes Control"},{"key":"427_CR84","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.cej.0000198897.40303.d4","volume":"15","author":"C Pelucchi","year":"2006","unstructured":"Pelucchi C, Talamini R, Negri E, Franceschi S, La Vecchia C. Genital and urinary tract diseases and prostate cancer risk. Eur J Cancer Prev. 2006;15:254\u20137.","journal-title":"Eur J Cancer Prev"},{"key":"427_CR85","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.juro.2006.04.075","volume":"176","author":"AV Sarma","year":"2006","unstructured":"Sarma AV, McLaughlin JC, Wallner LP, Dunn RL, Cooney KA, Schottenfeld D, Montie JE, Wei JT. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol. 2006;176:1108\u201313.","journal-title":"J Urol"},{"key":"427_CR86","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1158\/1055-9965.EPI-05-0913","volume":"15","author":"S Sutcliffe","year":"2006","unstructured":"Sutcliffe S, Giovannucci E, De Marzo AM, Leitzmann MF, Willett WC, Platz EA. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer. Cancer Epidemiol Biomark Prev. 2006;15:2160\u20136.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"427_CR87","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1158\/1055-9965.EPI-08-0173","volume":"17","author":"WY Huang","year":"2008","unstructured":"Huang WY, Hayes R, Pfeiffer R, Viscidi RP, Lee FK, Wang YF, Reding D, Whitby D, Papp JR, Rabkin CS. Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomark Prev. 2008;17:2374\u201381.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"427_CR88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2407-11-53","volume":"11","author":"J Hrbacek","year":"2011","unstructured":"Hrbacek J, Urban M, Hamsikova E, Tachezy R, Eis V, Brabec M, Heracek J. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer. 2011;11:53.","journal-title":"BMC Cancer"},{"key":"427_CR89","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canep.2015.12.001","volume":"40","author":"RA V\u00e1zquez-Salas","year":"2016","unstructured":"V\u00e1zquez-Salas RA, Torres-S\u00e1nchez L, L\u00f3pez-Carrillo L, Romero-Mart\u00ednez M, Manzanilla-Garc\u00eda HA, Cruz-Ort\u00edz CH, Mendoza-Pe\u00f1a F, Jim\u00e9nez-R\u00edos M\u00c1, Rodr\u00edguez-Covarrubias F, Hern\u00e1ndez-Tor\u00edz N, Moreno-Alc\u00e1zar O. History of gonorrhea and prostate cancer in a population-based case-control study in Mexico. Cancer Epidemiol. 2016;40:95\u2013101.","journal-title":"Cancer Epidemiol"},{"key":"427_CR90","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10096-016-2866-7","volume":"36","author":"YC Wang","year":"2017","unstructured":"Wang YC, Chung CH, Chen JH, Chiang MH, Ti-Yin CH, Tsao CH, Lin FH, Chien WC, Shang ST, Chang FY. Gonorrhea infection increases the risk of prostate cancer in Asian population: a nationwide population-based cohort study. Eur J Clin Microbiol Infect Dis. 2017;36:813\u201321.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"427_CR91","first-page":"506","volume":"37","author":"ML Taylor","year":"2005","unstructured":"Taylor ML, Mainous AG 3rd, Wells BJ. Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med. 2005;37:506\u201312.","journal-title":"Fam Med"},{"key":"427_CR92","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jso.2930160405","volume":"16","author":"G L\u00fcleci","year":"1981","unstructured":"L\u00fcleci G, Sakizli M, G\u00fcnalp A, Erkan I, Remzi D. Herpes simplex type 2 neutralization antibodies in patients with cancers of urinary bladder, prostate, and cervix. J Surg Oncol. 1981;16:327\u201331.","journal-title":"J Surg Oncol"},{"key":"427_CR93","first-page":"819","volume":"70","author":"I Boldogh","year":"1983","unstructured":"Boldogh I, Baskar JF, Mar EC, Huang ES. Human cytomegalovirus and herpes simplex type 2 virus in normal and adenocarcinomatous prostate glands. J Natl Cancer Inst. 1983;70:819\u201326.","journal-title":"J Natl Cancer Inst"},{"key":"427_CR94","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0090-4295(84)90118-3","volume":"24","author":"M Haid","year":"1984","unstructured":"Haid M, Sharon N. Immunofluorescent evidence of prior herpes simplex virus type-2 infection in prostate carcinoma. Urology. 1984;24:623\u20135.","journal-title":"Urology"},{"key":"427_CR95","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0090-4295(02)02166-0","volume":"61","author":"MJ Leskinen","year":"2003","unstructured":"Leskinen MJ, Vainionp R, Syrjnen S, Leppilahti M, Marttila T, Kylml T, Tammela TL. Herpes simplex virus, cytomegalovirus, and papillomavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer. Urology. 2003;61:397\u2013401.","journal-title":"Urology"},{"key":"427_CR96","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1086\/430354","volume":"191","author":"Z Korodi","year":"2005","unstructured":"Korodi Z, Wang X, Tedeschi R, Knekt P, Dillner J. No serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: a nested case-control study. J Infect Dis. 2005;191:2008\u201311.","journal-title":"J Infect Dis"},{"key":"427_CR97","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sj.bjc.6603480","volume":"96","author":"J Bergh","year":"2007","unstructured":"Bergh J, Marklund I, Gustavsson C, Wiklund F, Gr\u00f6nberg H, Allard A, Alexeyev O, Elgh F. No link between viral findings in the prostate and subsequent cancer development. Br J Cancer. 2007;96:137\u20139.","journal-title":"Br J Cancer"},{"key":"427_CR98","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1158\/1055-9965.EPI-08-1167","volume":"18","author":"LK Dennis","year":"2009","unstructured":"Dennis LK, Coughlin JA, McKinnon BC, Wells TS, Gaydos CA, Hamsikova E, Gray GC. Sexually transmitted infections and prostate cancer among men in the U.S. military. Cancer Epidemiol Biomark Prev. 2009;18:2665\u201371.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"427_CR99","unstructured":"Taylor M, Gerriets V. Acyclovir. 2021 Jun 28. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2021."},{"key":"427_CR100","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12885-021-08658-y","volume":"21","author":"JS Nahand","year":"2021","unstructured":"Nahand JS, Khanaliha K, Mirzaei H, Moghoofei M, Baghi HB, Esghaei M, Khatami AR, Fatemipour M, Bokharaei-Salim F. Possible role of HPV\/EBV coinfection in anoikis resistance and development in prostate cancer. BMC Cancer. 2021;21:926.","journal-title":"BMC Cancer"},{"key":"427_CR101","first-page":"4876","volume":"62","author":"S Grinstein","year":"2002","unstructured":"Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, Gould VE. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res. 2002;62:4876\u20138.","journal-title":"Cancer Res"},{"key":"427_CR102","doi-asserted-by":"crossref","unstructured":"De Paor M, O'Brien K, Fahey T, Smith SM. Antiviral agents for infectious mononucleosis (glandular fever). Cochrane Database Syst Rev. 2016;12:CD011487.","DOI":"10.1002\/14651858.CD011487.pub2"},{"key":"427_CR103","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41579-021-00582-z","volume":"19","author":"P Griffiths","year":"2021","unstructured":"Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021;19:759.","journal-title":"Nat Rev Microbiol"},{"key":"427_CR104","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3181\/00379727-174-41740","volume":"174","author":"Y Eizuru","year":"1983","unstructured":"Eizuru Y, Hyman RW, Nahhas WA, Rapp F. Herpesvirus RNA in human urogenital tumors. Proc Soc Exp Biol Med. 1983;174:296\u2013301.","journal-title":"Proc Soc Exp Biol Med"},{"key":"427_CR105","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","volume":"170","author":"M Samanta","year":"2003","unstructured":"Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol. 2003;170:998\u20131002.","journal-title":"J Urol"},{"key":"427_CR106","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<564::AID-IJC12>3.0.CO;2-9","volume":"75","author":"J Dillner","year":"1998","unstructured":"Dillner J, Knekt P, Boman J, Lehtinen M, Af Geijersstam V, Sapp M, et al. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer. 1998;75:564\u20137.","journal-title":"Int J Cancer"},{"key":"427_CR107","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.mcp.2014.01.006","volume":"28","author":"H Sellami","year":"2014","unstructured":"Sellami H, Said-Sadier N, Znazen A, Gdoura R, Ojcius DM, Hammami A. Chlamydia trachomatis infection increases the expression of inflammatory tumorigenic cytokines and chemokines as well as components of the Toll-like receptor and NF-\u03baB pathways in human prostate epithelial cells. Mol Cell Probes. 2014;28:147\u201354.","journal-title":"Mol Cell Probes"},{"key":"427_CR108","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1158\/1055-9965.EPI-03-0325","volume":"14","author":"T Anttila","year":"2005","unstructured":"Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M. Chlamydial antibodies and risk of prostate cancer. Cancer Epidemiol Biomark Prev. 2005;14:385\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"427_CR109","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1158\/1055-9965.EPI-07-0134","volume":"16","author":"S Sutcliffe","year":"2007","unstructured":"Sutcliffe S, Giovannucci E, Gaydos CA, Viscidi RP, Jenkins FJ, Zenilman JM, et al. Plasma antibodies against chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomark Prev. 2007;16:1573\u201380.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"427_CR110","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3109\/0284186X.2016.1139178","volume":"55","author":"S Lumme","year":"2016","unstructured":"Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J. Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer. Acta Oncol. 2016;55:839\u201345.","journal-title":"Acta Oncol"},{"key":"427_CR111","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/cid\/ciab044","volume":"73","author":"JL Blanco","year":"2021","unstructured":"Blanco JL, Fuertes I, Bosch J, De Lazzari E, Gonzalez-Cord\u00f3n A, Vergara A, Blanco-Arevalo A, Mayans J, Inciarte A, Estrach T, Martinez E, Cranston RD, Gatell JM, Alsina-Gibert M. Effective treatment of lymphogranuloma venereum proctitis with azithromycin. Clin Infect Dis. 2021;73:614\u201320.","journal-title":"Clin Infect Dis"},{"key":"427_CR112","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/QCO.0b013e3282f3d999","volume":"21","author":"VJ Johnston","year":"2008","unstructured":"Johnston VJ, Mabey DC. Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis. 2008;21:56\u201364.","journal-title":"Curr Opin Infect Dis"},{"key":"427_CR113","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/cid\/ciab514","volume":"73","author":"OT Van Gerwen","year":"2021","unstructured":"Van Gerwen OT, Camino AF, Sharma J, Kissinger PJ, Muzny CA. Epidemiology, natural history, diagnosis, and treatment of trichomonas vaginalis in men. Clin Infect Dis. 2021;73:1119\u201324.","journal-title":"Clin Infect Dis"},{"key":"427_CR114","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/ijc.24144","volume":"124","author":"S Sutcliffe","year":"2009","unstructured":"Sutcliffe S, Alderete JF, Till C, Goodman PJ, Hsing AW, Zenilman JM, De Marzo AM, Platz EA. Trichomonosis and subsequent risk of prostate cancer in the prostate cancer prevention trial. Int J Cancer. 2009;124:2082\u20137.","journal-title":"Int J Cancer"},{"key":"427_CR115","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/jnci\/djp306","volume":"101","author":"JR Stark","year":"2009","unstructured":"Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians\u2019 Health Study. J Natl Cancer Inst. 2009;101:1406\u201311.","journal-title":"J Natl Cancer Inst"},{"key":"427_CR116","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10552-012-0103-y","volume":"24","author":"YC Chen","year":"2013","unstructured":"Chen YC, Huang YL, Platz EA, Alderete JF, Zheng L, Rider JR, Kraft P, Giovannucci E, Sutcliffe S. Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer. Cancer Causes Control. 2013;24:175\u201380.","journal-title":"Cancer Causes Control"},{"key":"427_CR117","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/pros.23153","volume":"76","author":"IM Shui","year":"2016","unstructured":"Shui IM, Kolb S, Hanson C, Sutcliffe S, Rider JR, Stanford JL. Trichomonas vaginalis infection and risk of advanced prostate cancer. Prostate. 2016;76:620\u20133.","journal-title":"Prostate"},{"key":"427_CR118","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13104-016-2033-3","volume":"9","author":"JH Fowke","year":"2016","unstructured":"Fowke JH, Han X, Alderete JF, Moses KA, Signorello LB, Blot WJ. A prospective study of Trichomonas vaginalis and prostate cancer risk among African American men. BMC Res Notes. 2016;9:224.","journal-title":"BMC Res Notes"},{"key":"427_CR119","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10552-017-0919-6","volume":"28","author":"M Marous","year":"2017","unstructured":"Marous M, Huang WY, Rabkin CS, Hayes RB, Alderete JF, Rosner B, Grubb RL 3rd, Winter AC, Sutcliffe S. Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race\/ethnicity in the PLCO Trial. Cancer Causes Control. 2017;28:889\u201398.","journal-title":"Cancer Causes Control"},{"key":"427_CR120","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3347\/kjp.2019.57.1.21","volume":"57","author":"JH Kim","year":"2019","unstructured":"Kim JH, Moon HS, Kim KS, Hwang HS, Ryu JS, Park SY. Comparison of seropositivity to trichomonas vaginalis between men with prostatic tumor and normal men. Korean J Parasitol. 2019;57:21\u20135.","journal-title":"Korean J Parasitol"},{"key":"427_CR121","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00436-020-06942-7","volume":"120","author":"NE Saleh","year":"2021","unstructured":"Saleh NE, Alhusseiny SM, El-Zayady WM, Aboelnaga EM, El-Beshbishi WN, Saleh YM, Abou-ElWafa HS, El-Beshbishi SN. Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study. Parasitol Res. 2021;120:1379\u201388.","journal-title":"Parasitol Res"},{"key":"427_CR122","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/ijc.31885","volume":"144","author":"SH Tsang","year":"2019","unstructured":"Tsang SH, Peisch SF, Rowan B, Markt SC, Gonzalez-Feliciano AG, Sutcliffe S, Platz EA, Mucci LA, Ebot EM. Association between Trichomonas vaginalis and prostate cancer mortality. Int J Cancer. 2019;144:2377\u201380.","journal-title":"Int J Cancer"},{"key":"427_CR123","doi-asserted-by":"publisher","first-page":"289","DOI":"10.18632\/oncotarget.256","volume":"2","author":"YA Barykova","year":"2011","unstructured":"Barykova YA, Logunov DY, Shmarov MM, Vinarov AZ, Fiev DN, Vinarova NA, Rakovskaya IV, Baker PS, Shyshynova I, Stephenson AJ, Klein EA, Naroditsky BS, Gintsburg AL, Gudkov AV. Association of mycoplasma hominis infection with prostate cancer. Oncotarget. 2011;2:289\u201397.","journal-title":"Oncotarget"},{"key":"427_CR124","doi-asserted-by":"publisher","first-page":"102021","DOI":"10.1016\/j.canep.2021.102021","volume":"75","author":"OAG Tantengco","year":"2021","unstructured":"Tantengco OAG, Aquino IMC, de Castro SM, Rojo RD, Abad CLR. Association of mycoplasma with prostate cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2021;75:102021.","journal-title":"Cancer Epidemiol"},{"key":"427_CR125","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/1471-2407-11-233","volume":"11","author":"C Urbanek","year":"2011","unstructured":"Urbanek C, Goodison S, Chang M, Porvasnik S, Sakamoto N, Li CZ, Boehlein SK, Rosser CJ. Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer. BMC Cancer. 2011;11:233.","journal-title":"BMC Cancer"},{"key":"427_CR126","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11255-012-0299-5","volume":"45","author":"SM Erturhan","year":"2013","unstructured":"Erturhan SM, Bayrak O, Pehlivan S, Ozgul H, Seckiner I, Sever T, Karak\u00f6k M. Can mycoplasma contribute to formation of prostate cancer? Int Urol Nephrol. 2013;45:33\u20138.","journal-title":"Int Urol Nephrol"},{"key":"427_CR127","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/1471-2407-14-579","volume":"14","author":"MA Yow","year":"2014","unstructured":"Yow MA, Tabrizi SN, Severi G, Bolton DM, Pedersen J, Longano A, et al. Detection of infectious organisms in archival prostate cancer tissues. BMC Cancer. 2014;14:579.","journal-title":"BMC Cancer"},{"key":"427_CR128","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/cells8030212","volume":"8","author":"M Miyake","year":"2019","unstructured":"Miyake M, Ohnishi K, Hori S, Nakano A, Nakano R, Yano H, Ohnishi S, Owari T, Morizawa Y, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Tanaka N, Fujii T, Furuya H, Rosser CJ, Fujimoto K. Mycoplasma genitalium infection and chronic inflammation in human prostate cancer: detection using prostatectomy and needle biopsy specimens. Cells. 2019;8:212.","journal-title":"Cells"},{"key":"427_CR129","doi-asserted-by":"publisher","first-page":"ftaa037","DOI":"10.1093\/femspd\/ftaa037","volume":"78","author":"S Saadat","year":"2020","unstructured":"Saadat S, Karami P, Jafari M, Kholoujini M, Rikhtegaran Tehrani Z, Mohammadi Y, Alikhani MY. The silent presence of Mycoplasma hominis in patients with prostate cancer. Pathog Dis. 2020;78:ftaa037.","journal-title":"Pathog Dis"},{"key":"427_CR130","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/S1473-3099(20)30171-7","volume":"20","author":"AC Se\u00f1a","year":"2020","unstructured":"Se\u00f1a AC, Bachmann L, Johnston C, Wi T, Workowski K, Hook EW 3rd, Hocking JS, Drusano G, Unemo M. Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction. Lancet Infect Dis. 2020;20:e181\u201391.","journal-title":"Lancet Infect Dis"},{"key":"427_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1999.0092","volume":"267","author":"MJ Imperiale","year":"2000","unstructured":"Imperiale MJ. The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. Virology. 2000;267:1\u20137.","journal-title":"Virology"},{"key":"427_CR132","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/viro.1995.9928","volume":"214","author":"P Monini","year":"1995","unstructured":"Monini P, Rotola A, Di Luca D, De Lellis L, Chiari E, Corallini A, Cassai E. DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology. 1995;214:273\u20139.","journal-title":"Virology"},{"key":"427_CR133","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/pros.10157","volume":"53","author":"A Zambrano","year":"2002","unstructured":"Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate. 2002;53:263\u201376.","journal-title":"Prostate"},{"key":"427_CR134","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1600-0463.2007.apm_601.x","volume":"115","author":"SK Lau","year":"2007","unstructured":"Lau SK, Lacey SF, Chen YY, Chen WG, Weiss LM. Low frequency of BK virus in prostatic adenocarcinomas. APMIS. 2007;115:743\u20139.","journal-title":"APMIS"},{"key":"427_CR135","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1128\/JVI.02461-07","volume":"82","author":"D Das","year":"2008","unstructured":"Das D, Wojno K, Imperiale MJ. BK virus as a cofactor in the etiology of prostate cancer in its early stages. J Virol. 2008;82:2705\u201314.","journal-title":"J Virol"},{"key":"427_CR136","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1002\/jmv.21312","volume":"80","author":"G Russo","year":"2008","unstructured":"Russo G, Anzivino E, Fioriti D, Mischitelli M, Bellizzi A, Giordano A, Autran-Gomez A, Di Monaco F, Di Silverio F, Sale P, Di Prospero L, Pietropaolo V. p53 gene mutational rate, Gleason score, and BK virus infection in prostate adenocarcinoma: Is there a correlation? J Med Virol. 2008;80:2100\u20137.","journal-title":"J Med Virol"},{"key":"427_CR137","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00430-013-0304-3","volume":"202","author":"S Delbue","year":"2013","unstructured":"Delbue S, Matei DV, Carloni C, Pecchenini V, Carluccio S, Villani S, Tringali V, Brescia A, Ferrante P. Evidence supporting the association of polyomavirus BK genome with prostate cancer. Med Microbiol Immunol. 2013;202:425\u201330.","journal-title":"Med Microbiol Immunol"},{"key":"427_CR138","first-page":"2240","volume":"12","author":"A Taghavi","year":"2015","unstructured":"Taghavi A, Mohammadi-Torbati P, Kashi AH, Rezaee H, Vaezjalali M. Polyomavirus hominis 1(BK virus) Infection in prostatic tissues: cancer versus hyperplasia. Urol J. 2015;12:2240\u20134.","journal-title":"Urol J"},{"key":"427_CR139","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13027-019-0244-7","volume":"14","author":"BMT Gorish","year":"2019","unstructured":"Gorish BMT, Ournasseir MEH, Shammat IM. A correlation study of BK polyoma virus infection and prostate cancer among sudanese patients - immunofluorescence and molecular based case-control study. Infect Agent Cancer. 2019;14:25.","journal-title":"Infect Agent Cancer"},{"key":"427_CR140","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11934-996-0012-2","volume":"7","author":"GJ Wise","year":"2006","unstructured":"Wise GJ, Shteynshlyuger A. How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep. 2006;7:320\u20138.","journal-title":"Curr Urol Rep"},{"key":"427_CR141","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.1349-7006.1991.tb01814.x","volume":"82","author":"W Wajjwalku","year":"1991","unstructured":"Wajjwalku W, Takahashi M, Miyaishi O, Lu J, Sakata K, Yokoi T, Saga S, Imai M, Matsuyama M, Hoshino M. Tissue distribution of mouse mammary tumor virus (MMTV) antigens and new endogenous MMTV loci in Japanese laboratory mouse strains. Jpn J Cancer Res. 1991;82:1413\u201320.","journal-title":"Jpn J Cancer Res"},{"key":"427_CR142","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/j.seminoncol.2014.12.029","volume":"42","author":"AE Grulich","year":"2015","unstructured":"Grulich AE, Vajdic CM. The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin Oncol. 2015;42:247\u201357.","journal-title":"Semin Oncol"},{"key":"427_CR143","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/jnci\/djy010","volume":"110","author":"AE Coghill","year":"2018","unstructured":"Coghill AE, Engels EA, Schymura MJ, Mahale P, Shiels MS. Risk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States. J Natl Cancer Inst. 2018;110:959\u201366.","journal-title":"J Natl Cancer Inst"},{"key":"427_CR144","doi-asserted-by":"publisher","first-page":"104946","DOI":"10.1016\/j.meegid.2021.104946","volume":"93","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Li L, Chen J, Wei G, Ji Y, Chen X, Liu J, Huo J. Human gut-microbiome interplay: analysis of clinical studies for the emerging roles of diagnostic microbiology in inflammation, oncogenesis and cancer management. Infect Genet Evol. 2021;93:104946.","journal-title":"Infect Genet Evol"},{"key":"427_CR145","first-page":"122","volume":"111","author":"DM Golombos","year":"2018","unstructured":"Golombos DM, Ayangbesan A, O\u2019Malley P, Lewicki P, Barlow L, Barbieri CE, et al. The role of gut microbiome in the pathogenesis of prostate cancer: a prospective. Pilot Study Urol. 2018;111:122\u20138.","journal-title":"Pilot Study Urol"},{"key":"427_CR146","unstructured":"Gallego L, Dominguez A, Parmar M. Human papilloma virus vaccine. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2021."},{"key":"427_CR147","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","volume":"20","author":"JS de Bono","year":"2020","unstructured":"de Bono JS, Guo C, Gurel B, De Marzo AM, Sfanos KS, Mani RS, Gil J, Drake CG, Alimonti A. Prostate carcinogenesis: inflammatory storms. Nat Rev Cancer. 2020;20:455\u201369.","journal-title":"Nat Rev Cancer"},{"key":"427_CR148","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.3390\/ijms22105078","volume":"22","author":"A G\u00f6bel","year":"2021","unstructured":"G\u00f6bel A, Dell\u2019Endice S, Jaschke N, P\u00e4hlig S, Shahid A, Hofbauer LC, Rachner TD. The role of inflammation in breast and prostate cancer metastasis to bone. Int J Mol Sci. 2021;22:5078.","journal-title":"Int J Mol Sci"},{"key":"427_CR149","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","volume":"118","author":"FR Greten","year":"2004","unstructured":"Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285\u201396.","journal-title":"Cell"},{"key":"427_CR150","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12885-018-4156-5","volume":"18","author":"Y Qiao","year":"2018","unstructured":"Qiao Y, Yang T, Gan Y, Li W, Wang C, Gong Y, Lu Z. Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies. BMC Cancer. 2018;18:288.","journal-title":"BMC Cancer"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-022-00427-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:20:21Z","timestamp":1700652021000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-022-00427-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s13027-022-00427-1","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"James Lawson declares he has no competing financial or intellectual interests. Wendy Glenn declares she has no competing financial or intellectual interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}